Ultraviolet A phototherapy for sclerotic skin diseases: A systematic review
Authors:
- Elisabeth B.M. KroftEKElisabeth B.M. Kroft
- Nadine J.G. BerkhofNBNadine J.G. Berkhof
- Peter C.M. van de KerkhofPKPeter C.M. van de Kerkhof
- Rianne M.J.P. GerritsenRGRianne M.J.P. Gerritsen
- Elke M.G.J. de JongEJElke M.G.J. de Jong
- 1 December 2008
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 59 (6) , 1017-1030
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United StatesPhotodermatology, Photoimmunology & Photomedicine, 2006
- A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized sclerodermaJournal of the American Academy of Dermatology, 2006
- Use of Imiquimod Cream 5% in the Treatment of Localized MorpheaJournal of Cutaneous Medicine and Surgery, 2004
- Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblastsArthritis & Rheumatism, 2003
- Ultraviolet A1 phototherapyBritish Journal of Dermatology, 2003
- Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cellsJournal of the American Academy of Dermatology, 2001
- UVA therapy for sclerodermaJournal of the American Academy of Dermatology, 1999
- Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized sclerodermaJournal of the American Academy of Dermatology, 1997
- Decreased Expression of the Human Progenitor Cell Antigen (CD34) in MorpheaThe American Journal of Dermatopathology, 1995
- High-dose UVA1 therapy in the treatment of patients with atopic dermatitisJournal of the American Academy of Dermatology, 1992